Back to Agenda
Today's Dynamic Medical Science Liaison Environment
Session Chair(s)
Geoff Brockway
Director, Global MSL Excellence
AstraZeneca, United Kingdom
Medical Science Liaison (MSL) organizations continue to expand and evolve secondary to the evolving needs within the pharmaceutical industry. A changing customer base, new and expanded regulations, and the growing complexity of therapeutic agents, offer new opportunities for the continued expansion and evolution of the MSL role. Currently, MLSs are engaged in clinical trial related activities, managed care and heath economics discussions, business development projects, and other activities. In this session, a diverse group of MSL representatives will share why these roles are critical and how they contribute to the overall medical affairs objectives.
Learning Objective : Discuss the critical role of the MSL; Describe the evolution of the MSL role.
Speaker(s)
Industry Perspective
David A. Jencen, PhD
Jencen Field Medical Consulting LLC, United States
Principal
Industry Perspective
Neil H. Gray
Inventiv Therapeutics Institute, United States
Senior Vice President, Medical Affairs
Have an account?